Philexis SRL
Philexis reported total assets of 101,847 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026).
The score of Philexis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +120 % Total assets +66 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Philexis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 18 Jan 2023
Philexis's financial analysis
- Solvency93.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Philexis
Philexis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.977.947
- VAT number
- BE0762977947
- Peppol
- Registered · 0208:0762977947 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Feb 2021
- Registered office
- 1950 Kraainem
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Philexis (SRL) has been based in Kraainem since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 18,878 € and equity of 95,403 €; its revenue is not published. Its solvency stands at 93.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Philexis
Companies in the same business, of comparable size and area, outside its group.
- Ingrid Luyten Retail sale of pharmaceutical products Turnhout · balance sheet 100,696 €
- Apotheek de Linde Retail sale of pharmaceutical products Hoeilaart · balance sheet 99,970 €
- Mencina Retail sale of pharmaceutical products Antwerp · balance sheet 99,620 €
- Rechter Apotheke Retail sale of pharmaceutical products Sankt Vith · balance sheet 105,065 €
- Pharmacie Thonon Retail sale of pharmaceutical products Orp-Jauche · balance sheet 101,626 €
- Societe Pharmaceutique de Gestion Retail sale of pharmaceutical products Ixelles · balance sheet 86,711 €
- SAB Pharma Retail sale of pharmaceutical products Péruwelz · balance sheet 106,135 €
- Merckx Retail sale of pharmaceutical products Wichelen · balance sheet 106,701 €
Frequently asked questions about Philexis
What is the revenue of Philexis?
Philexis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Philexis?
In Belgium, the VAT number is the company number prefixed with BE: BE0762977947 for Philexis, if the company is VAT-registered. Its company number (CBE) is 0762.977.947.
Where is the registered office of Philexis?
According to the CBE register, the registered office of Philexis is in 1950 Kraainem.
What is the equity of Philexis?
At the close of the 2025 financial year, the equity of Philexis amounts to 95,403 €, a solvency of 93.7% of total assets.
Who manages Philexis?
The register lists 1 active mandates at Philexis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Philexis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →